Bayer adds $1.37 billion to Roundup litigation reserves
German pharmaceutical and biotechnology group Bayer said today it had set aside an additional €1.2 billion in provisions to address ongoing litigation in the US over weed killer Roundup.
Business
• 01 Aug
